Vocabria Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

Tablet: White, oval, film-coated tablets, debossed with 'SV CTV' on one side.
Each tablet contains cabotegravir sodium equivalent to 30 mg cabotegravir.
Excipient with known effect: Each film-coated tablet contains 155 mg lactose (as monohydrate).
Suspension for injection: White to light pink suspension.
Each vial contains 600 mg cabotegravir in 3 mL.
Excipients/Inactive Ingredients: Tablet: Tablet core: Lactose monohydrate, Microcrystalline cellulose, Hypromellose, Sodium starch glycolate (Type A), Magnesium stearate.
Tablet coating: Hypromellose (E464), Titanium dioxide (E171), Macrogol (E1521).
Suspension for injection: Mannitol, Polysorbate 20, Macrogol 3350, Water for injections.

cabotegravir

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig

Marketer:

GlaxoSmithKline